News

EMD Serono Media Center

Immerse yourself in the fascinating world of a healthcare company. Explore the latest news from the media center and stay up-to-date.

Latest News

View all news
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with ...

    Enpatoran, an oral TLR7/8 inhibitor, is designed for lupus patients with active cutaneous manifestations, with the goal of broadening the treatment paradigm beyond the current standards

    2026/04/30

  2. Press Releases

    EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with ...

    The company's complete fertility medication portfolio, including Gonal‑f®, the most‑prescribed follicle‑stimulating hormone in the U.S., is now accessible via TrumpRx.gov and FertilityInstantSavings.com

    2026/02/06

  3. Press Releases

    FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial ...

    The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study.

    2026/01/12

  • Get in Touch

    Contact the EMD Serono US Communications Team via email.

    Email Us
  • Media Downloads

    Browse and download high-quality images and video footage.
    Access gallery
  • Press Releases

    Browse our news releases or filter by topic, year, and month.

    Press Releases